Share. Connect. Create. Grow. · Socialiya
Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-...

HEALTH NEWS May 30, 2026

Groundbreaking genomic test could spare millions of breast cancer patients chemotherapy

Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes.

14 views 0 likes 0 comments
Share:
Trial suggests patients with a low test score could be treated with hormone therapy alone with near-identical outcomes.

Author: The Guardian

Read Original Article

Related News

Latest News

Advertisement

Top Categories

Advertisement
Advertisement
Advertisement
Advertisement